{"id":837967,"date":"2025-04-16T08:21:22","date_gmt":"2025-04-16T12:21:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/"},"modified":"2025-04-16T08:21:22","modified_gmt":"2025-04-16T12:21:22","slug":"vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/","title":{"rendered":"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif., April  16, 2025  (GLOBE NEWSWIRE) &#8212; Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine Congress Washington 2025 in Washington, D.C. on Wednesday, April 23, 2025. The Company has appeared repeatedly at the annual event in Washington, D.C.<\/p>\n<p align=\"justify\">\n        <strong>Presentation Information:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>Moving the needle: Blocking transmission and boosting existing vaccines by oral tablet vaccination<br \/><strong>Speaker: <\/strong>Dr. James F. Cummings<br \/><strong>Date: <\/strong>Wednesday, April 23, 2025 <br \/><strong>Time:<\/strong> 1:10 p.m. ET<br \/><strong>Room:<\/strong> 207A<\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>Immune profiling on an oral norovirus vaccine candidate; correlates of protection for disease and infection<br \/><strong>Speaker: <\/strong>Dr. Sean Tucker<br \/><strong>Date: <\/strong>Wednesday, April 23, 2024 <br \/><strong>Time:<\/strong> 3:10 p.m. ET<br \/><strong>Room:<\/strong> 207A<\/p>\n<p>\n        <strong>About Vaxart<\/strong>\n      <\/p>\n<p align=\"justify\">Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart\u2019s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart\u2019s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.<\/p>\n<p>\n        <strong>Contact<\/strong><br \/>\n        <br \/>\n        <strong>Vaxart Media and Investor Relations<\/strong>:\u202f\u202f\u00a0<br \/>Matt Steinberg \u202f\u202f\u202f\u202f <br \/>FINN Partners<br \/>IR@vaxart.com<br \/>(646) 871-8481<\/p>\n<p>This press release was published by a CLEAR\u00ae Verified individual.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTcxZTFlMjEtMmU5NC00MWIyLTlmYzUtNTM1NDk3ZGNjMDM0LTEwMzA2ODItMjAyNS0wNC0xNi1lbg==\/tiny\/Vaxart-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) &#8212; Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine Congress Washington 2025 in Washington, D.C. on Wednesday, April 23, 2025. The Company has appeared repeatedly at the annual event in Washington, D.C. Presentation Information: Title: Moving the needle: Blocking transmission and boosting existing vaccines by oral tablet vaccinationSpeaker: Dr. James F. CummingsDate: Wednesday, April 23, 2025 Time: 1:10 p.m. ETRoom: 207A Title: Immune profiling on an oral norovirus vaccine candidate; correlates of protection for disease and infectionSpeaker: Dr. Sean TuckerDate: Wednesday, April 23, 2024 Time: 3:10 p.m. ETRoom: 207A About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vaxartto Present at World Vaccine Congress Washington 2025 on April 23&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837967","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) &#8212; Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine Congress Washington 2025 in Washington, D.C. on Wednesday, April 23, 2025. The Company has appeared repeatedly at the annual event in Washington, D.C. Presentation Information: Title: Moving the needle: Blocking transmission and boosting existing vaccines by oral tablet vaccinationSpeaker: Dr. James F. CummingsDate: Wednesday, April 23, 2025 Time: 1:10 p.m. ETRoom: 207A Title: Immune profiling on an oral norovirus vaccine candidate; correlates of protection for disease and infectionSpeaker: Dr. Sean TuckerDate: Wednesday, April 23, 2024 Time: 3:10 p.m. ETRoom: 207A About &hellip; Continue reading &quot;Vaxartto Present at World Vaccine Congress Washington 2025 on April 23&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-16T12:21:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23\",\"datePublished\":\"2025-04-16T12:21:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/\"},\"wordCount\":283,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/\",\"name\":\"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=\",\"datePublished\":\"2025-04-16T12:21:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/","og_locale":"en_US","og_type":"article","og_title":"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) &#8212; Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine Congress Washington 2025 in Washington, D.C. on Wednesday, April 23, 2025. The Company has appeared repeatedly at the annual event in Washington, D.C. Presentation Information: Title: Moving the needle: Blocking transmission and boosting existing vaccines by oral tablet vaccinationSpeaker: Dr. James F. CummingsDate: Wednesday, April 23, 2025 Time: 1:10 p.m. ETRoom: 207A Title: Immune profiling on an oral norovirus vaccine candidate; correlates of protection for disease and infectionSpeaker: Dr. Sean TuckerDate: Wednesday, April 23, 2024 Time: 3:10 p.m. ETRoom: 207A About &hellip; Continue reading \"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-16T12:21:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23","datePublished":"2025-04-16T12:21:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/"},"wordCount":283,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/","name":"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=","datePublished":"2025-04-16T12:21:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzEzMCM2ODY4Nzg2IzIwMTkxMDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxartto-present-at-world-vaccine-congress-washington-2025-on-april-23\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vaxartto Present at World Vaccine Congress Washington 2025 on April 23"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837967"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837967\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}